Contrasting SPK Acquisition (NASDAQ:SPK) and Ikena Oncology (NASDAQ:IKNA)
Ikena Oncology (NASDAQ:IKNA – Get Rating) and SPK Acquisition (NASDAQ:SPK – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based
Defense WorldJan 2, 2023 05:11 ET
SPK Acquisition Terminates Merger Agreement With Varian Biopharmaceuticals
01:52 PM EST, 12/27/2022 (MT Newswires) -- SPK Acquisition (SPK) said it terminated its merger agreement with Varian Biopharmaceuticals. SPK said in a regulatory filing it sent a notice to Varian term
MT NewswiresDec 27, 2022 13:52 ET
SPAC SPK Scraps Merger With Varian, Will Liquidate Instead on Dec. 29
Seeking AlphaDec 27, 2022 12:33 ET
SPK Acquisition Corp. On Dec. 21 Sent Varian Notice That SPK Had Terminated The Merger Agreement, Alleging 'Certain Breaches by Varian of One or More Covenants Contained in the Merger Agreement.'
SPK Acquisition Corp. On Dec. 21 Sent Varian Notice That SPK Had Terminated The Merger Agreement, Alleging 'certain breaches by Varian of one or more covenants contained in the Merger Agreement.'
Benzinga Real-time NewsDec 27, 2022 06:07 ET
SPK Acquisition Corp. (NASDAQ:SPK) Short Interest Update
SPK Acquisition Corp. (NASDAQ:SPK – Get Rating) was the recipient of a significant increase in short interest in November. As of November 15th, there was short interest totalling 1,100 shares, an in
kopsourceNov 30, 2022 17:01 ET
Varian Biopharmaceuticals to go public through merger with SPAC SPK Acquisition
Varian Biopharmaceuticals plans to go public through a merger with SPAC SPK Acquisition Corp (NASDAQ:SPK). The combined company's post-transaction equity value is expected to be around $116M. The dea
Seeking AlphaFeb 15, 2022 13:28 ET
SPK Acquisition Enters Deal to Merge With Varian Biopharmaceuticals
09:51 AM EST, 02/14/2022 (MT Newswires) -- SPK Acquisition Corp. (SPK) said Monday it has agreed to merge with privately owned Varian Biopharmaceuticals to create a combined company with an expected
MT NewswiresFeb 14, 2022 09:58 ET
BRIEF-Varian Biopharmaceuticals, Inc To Become Publicly Traded Through A Merger With Spk Acquisition Corp.
Feb 14 (Reuters) - SPK Acquisition Corp SPK.O :* VARIAN BIOPHARMACEUTICALS, INC., A PRECISION ONCOLOGY COMPANY, TO BECOME PUBLICLY TRADED THROUGH A MERGER WITH SPK ACQUISITION CORP.* SPK ACQUISITION
reutersFeb 14, 2022 09:40 ET
SPK Acquisition in Deal to Take Varian Bio Public
By Chris Wack SPK Acquisition Corp. on Monday said it was in a deal to make Varian Biopharmaceuticals Inc. a publicly traded company. The special purpose acquisition company said Varian B
Dow Jones NewswiresFeb 14, 2022 09:22 ET
News On SPK Acquisition Corp. (SPKAU) Now Under SPK
*DJ News On SPK Acquisition Corp. (SPKAU) Now Under SPK (END) Dow Jones Newswires July 23, 2021 17:08 ET (21:08 GMT) Copyright (c) 2021 Dow Jones & Company, Inc.
Dow Jones NewswiresJul 23, 2021 17:08 ET
No Data
No Data